In a report released today, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Prenetics Group (PRE – Research Report), with a price ...
Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research Report) on January 14 and set a price ...
Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Nova (NasdaqGS:NVMI) with a Overweight ...
Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Camtek (NasdaqGM:CAMT) with a Neutral ...
We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Stock analysts at Cantor Fitzgerald dropped their FY2024 earnings per share estimates for Maplebear in a research note issued on Tuesday, January 7th. Cantor Fitzgerald analyst D. Mathivanan now ...
Equities researchers at Cantor Fitzgerald increased their FY2024 earnings estimates for shares of MercadoLibre in a report issued on Tuesday, January 7th. Cantor Fitzgerald analyst D. Mathivanan now ...
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering ...
Monday - Cantor Fitzgerald has initiated coverage on Onto Innovation Inc. (NYSE: NYSE:ONTO) shares with an Overweight rating and has set a price target of $250. The new rating is based on the firm ...
NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering of 20,000,000 Class A ordinary ...
Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a Overweight recommendation. As of December 23, 2024, the average one ...